NCT04267185

Brief Summary

Both people with multiple sclerosis (MS) and their family caregivers experience the impact of this neurodegenerative disease on their health and well-being. The person living with MS and their support partner need to work together as a team to find ways to manage the disease. A physical activity (PA) program that uses a 'dyadic approach' is one possible way of managing the impact of MS. Dyadic programs are unique because they target both people with the disease and their caregivers together to increase their PA levels. This pilot study will deliver a 12-week program using group teleconference and one-on-one support phone calls to teach participants simple methods to change PA patterns in daily life. For example, they will learn how to set personal goals to increase PA and reduce sitting time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2020

Completed
19 days until next milestone

Study Start

First participant enrolled

February 4, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 12, 2020

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 4, 2022

Completed
Last Updated

December 12, 2024

Status Verified

May 1, 2023

Enrollment Period

2.4 years

First QC Date

January 16, 2020

Last Update Submit

December 6, 2024

Conditions

Keywords

ExerciseCaregiverPhysical Activity

Outcome Measures

Primary Outcomes (10)

  • Safety of the PAT-MS intervention

    Safety will be recorded via reporting of adverse events (AEs) during testing sessions and one-on-one support calls. AEs will be defined as any unfavorable change in health that occurs in both PwMS and CGs during the trial period, e.g. injuries, relapses, falls and symptomatic changes. Each AE will be rated based on severity, expectedness, and potential relation to study participation using the Common Terminology for Adverse Events (CTCAE) classification scheme. AEs will be reported as the overall rate, severity, and characteristics of the events.

    Assessed weekly through study completion at 12 weeks

  • Feasibility: Participant recruitment rate

    We will use phone call and electronic mail recruitment and record all contact with potential participants and refusal reasons.

    Recorded through the 6-month recruitment period

  • Feasibility: Participant compliance rate

    Will be assessed by recording the number of practice activities, group teleconference sessions, and one-on-one phone calls completed by participants.

    Recorded weekly through study completion at 12 weeks

  • Feasibility: Participant attrition rate

    Will be assessed as the percentage of the sample who drop out of the study.

    Will be assessed at T2 (12 Weeks)

  • Feasibility: Monetary cost of research

    We will establish and record all monetary costs for the study.

    Recorded from study initiation to completion, approximately 2 years

  • Feasibility: Staff time

    We will document all preparation, call time, attempted call time and report-taking time for each participant during the intervention.

    Recorded weekly through study completion at 12 weeks

  • Feasibility: Research ethics procedures

    We will document communications between the research ethics board and staff, and time from submission of research ethics application to approval.

    Recorded from study initiation to completion, approximately 2 years

  • Feasibility: Data collection at T1

    We will check for data completeness, and record time to collect, enter and check data in a database

    Will be assessed at T1 (Baseline)

  • Feasibility: Data collection at T2

    We will check for data completeness, and record time to collect, enter and check data in a database

    Will be assessed at T2 (12 Weeks)

  • Change in Self-Reported Physical Activity - Primary Efficacy Outcome

    Change in Self-reported physical activity (PA) level of PwMS and CGs will be assessed using the Godin Leisure-Time Exercise Questionnaire (GLTEQ). The GLTEQ has been demonstrated to be a reliable and valid primary outcome for measuring change in PA in response to a behavioural intervention.

    Change in Self-reported PA (total PA minutes) between T1 (Baseline) and T2 (12 Weeks)

Secondary Outcomes (13)

  • Change in Accelerometer-measured Physical Activity - steps/day

    Change in accelerometer-measured steps/day between T1 (Baseline) and T2 (12 Weeks).

  • Change in Accelerometer-measured Physical Activity - minutes of PA

    Change in accelerometer-measured minutes of PA between T1 (Baseline) and T2 (12 Weeks).

  • Change in Walking Speed

    Change in walking speed between T1 (Baseline) and T2 (12 Weeks).

  • Change in Walking Endurance

    Change in Walking endurance between T1 (Baseline) and T2 (12 Weeks)

  • Change in Agility

    Change in Agility between T1 (Baseline) and T2 (12 Weeks).

  • +8 more secondary outcomes

Other Outcomes (3)

  • Satisfaction Survey

    T2 (12 Weeks)

  • Experiential Aspects of Participation

    T2 (12 Weeks)

  • Semi-structured Qualitative Interview

    T2 (12 Weeks)

Study Arms (2)

Immediate Intervention

EXPERIMENTAL

PwMS-CG dyads will receive six group telerehabilitation sessions (\~60 min each) every other week for a period of 12 weeks. This will be interspersed with brief one-on-one support telephone calls in the weeks that group sessions do not occur. All participants will be taught techniques for monitoring PA behaviour, setting personalized goals to increase PA and reduce sedentary time, and strategies for overcoming challenges to PA participation. Make-up sessions will be offered to those who miss group sessions. The one-on-one support telephone calls will serve to reinforce the information provided during the group sessions, monitor safety and troubleshoot any issues with intervention content.

Behavioral: Physical Activity Together for PwMS and their CGs (PAT-MS)

Delayed Control

NO INTERVENTION

The delayed control group will not receive the intervention during the study period. Participants assigned to the control group will be offered the intervention once the study is completed.

Interventions

A dyadic physical activity intervention approach for PwMS and their family CGs affected by moderate-to-severe MS disability.

Immediate Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For persons with MS:
  • Physician-confirmed MS diagnosis and stable course of disease modifying therapies over the past 6 months
  • Expanded Disability Status Scale (EDSS) score between 6.0 (intermittent or unilateral constant assistance (cane, crutch, brace) required to walk about 100 meters with or without resting) and 6.5 (constant bilateral assistance (canes, crutches, braces) required to walk about 20 meters without resting), based on a Neurostatus-certified assessor examination.
  • Relapse-free in the past 30 days
  • Support Partner (i.e., relative or close friend) who provides greater than or equal to 1.0 hours per day of unpaid care
  • Greater than or equal to 18 years of age
  • Currently inactive (i.e., purposeful exercise less than or equal to 2 days/week for 30 minutes)
  • Asymptomatic (i.e. no major signs or symptoms of acute or uncontrolled cardiovascular, metabolic, or renal disease) based on the Get Active Questionnaire
  • Ability to communicate in English

You may not qualify if:

  • diagnosis of other neurological condition(s)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ottawa

Ottawa, Ontario, K1N 6N5, Canada

Location

Related Publications (5)

  • Fakolade A, Lamarre J, Latimer-Cheung A, Parsons T, Morrow SA, Finlayson M. Understanding leisure-time physical activity: Voices of people with MS who have moderate-to-severe disability and their family caregivers. Health Expect. 2018 Feb;21(1):181-191. doi: 10.1111/hex.12600. Epub 2017 Jul 19.

    PMID: 28722772BACKGROUND
  • Fakolade A, Latimer-Cheung A, Parsons T, Finlayson M. A concerns report survey of physical activity support needs of people with moderate-to-severe MS disability and family caregivers. Disabil Rehabil. 2019 Dec;41(24):2888-2899. doi: 10.1080/09638288.2018.1479781. Epub 2018 Jun 29.

    PMID: 29958014BACKGROUND
  • Fakolade A, Finlayson M, Parsons T, Latimer-Cheung A. Correlating the Physical Activity Patterns of People with Moderate to Severe Multiple Sclerosis Disability and Their Family Caregivers. Physiother Can. 2018 Fall;70(4):373-381. doi: 10.3138/ptc.2017-36.ep.

    PMID: 30745723BACKGROUND
  • Fakolade A, Awadia Z, Cardwell K, McKenna O, Venasse M, Hume T, Ludgate J, Freedman MS, Finlayson M, Latimer-Cheung AE, Pilutti LA. Physical Activity Together for Multiple Sclerosis (PAT-MS): A randomized controlled feasibility trial of a dyadic behaviour change intervention. Contemp Clin Trials Commun. 2023 Oct 16;36:101222. doi: 10.1016/j.conctc.2023.101222. eCollection 2023 Dec.

  • Fakolade A, Cameron J, McKenna O, Finlayson ML, Freedman MS, Latimer-Cheung AE, Pilutti LA. Physical Activity Together for People With Multiple Sclerosis and Their Care Partners: Protocol for a Feasibility Randomized Controlled Trial of a Dyadic Intervention. JMIR Res Protoc. 2021 Jun 1;10(6):e18410. doi: 10.2196/18410.

MeSH Terms

Conditions

Multiple SclerosisMotor Activity

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Study Officials

  • Lara Pilutti, PhD

    University of Ottawa

    PRINCIPAL INVESTIGATOR
  • Mark Freedman, MD

    The Ottawa Hospital/Ottawa Hospital Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessments will be collected objectively by researchers who are blinded to treatment allocation. Researchers who are involved with delivery of the intervention will be aware of treatment allocation, but will not be involved with data collection, entry or analysis.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This pilot study will use a two-arm, parallel group, single-blinded RCT design that examines the feasibility and preliminary efficacy of a twelve-week physical activity intervention in persons with moderate-to-severe MS disability and their family caregivers compared with a delayed control condition.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 16, 2020

First Posted

February 12, 2020

Study Start

February 4, 2020

Primary Completion

June 12, 2022

Study Completion

October 4, 2022

Last Updated

December 12, 2024

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations